I-Chlorothiazide

Incazelo emfushane:

Igama le-API Inkomba Ukucaciswa I-US DMF I-EU DMF CEP
I-Chlorothiazide Ama-diuretics USP/EP      


Imininingwane Yomkhiqizo

Omaka bomkhiqizo

IMINININGWANE YOMKHIQIZO

Ingemuva

I-Chlorothiazide iyi-inhibitor ye-carbonic anhydrase futhi inamandla amancane kune-acetazolamide. Lesi sakhi siboniswe ukuthi sivimba ukumuncwa kabusha kwe-sodium ne-chloride ion.

Incazelo

I-Chlorothiazide iyi-diuretic ne-antihypertensive. (IC50=3.8 mM) Okuqondisiwe: Okunye I-Chlorothiazide sodium (Diuril) iwumuthi wokukhipha isisu osetshenziswa ngaphakathi kwelungiselelo lasesibhedlela noma ukuze uyisebenzisele wena ukulawula uketshezi oluningi oluhambisana nokuqunjelwa kwenhliziyo. Ibuye isetshenziswe njenge-antihypertensive. Okuvame ukuthathwa njengephilisi, ngokuvamile liphuzwa ngomlomo kanye noma kabili ngosuku. Esimweni se-ICU, i-chlorothiazide inikezwa ukuhlanza isiguli ngaphezu kwe-furosemide (Lasix). Isebenza ngendlela ehlukile kune-furosemide, futhi imuncwe ngokungenisa njengokumiswa kabusha okulawulwa ngeshubhu le-nasogastric (NG tube), le mithi emibili inamandla enye kwenye.

Ukuhlolwa Komtholampilo

Inombolo ye-NCT Umxhasi Isimo Usuku okuqalwa ngalo

Isigaba

I-NCT03574857 Inyuvesi yaseVirginia Ukwehluleka Kwenhliziyo|Ukwehluleka Kwenhliziyo Ngengxenyana Eyehlisiwe Yokukhipha|Ukwehluleka Kwenhliziyo Kushubile|Izifo Zenhliziyo Juni 2018

Isigaba 4

I-NCT02546583 Yale University|National Heart, Lung, and Blood Institute (NHLBI) Ukuhluleka Kwenhliziyo Agasti 2015

Akufaneleki

I-NCT02606253 I-Vanderbilt University|Vanderbilt University Medical Center Ukuhluleka Kwenhliziyo February 2016

Isigaba 4

I-NCT00004360 Isikhungo Sikazwelonke Sezinsiza Zocwaningo (NCRR)|Northwestern University|Office of Rare Diseases (ORD) Isifo sikashukela i-Insipidus, i-Nephrogenic Septhemba 1995

I-NCT00000484 National Heart, Lung, and Blood Institute (NHLBI) Izifo Zenhliziyo | Izifo Zenhliziyo | Umfutho Wegazi | Izifo Zemithambo Ephreli 1966

Isigaba 3

Isakhiwo samakhemikhali

I-Chlorothiazide

ISItifiketi

2018 GMP-2
原料药GMP证书201811 (captopril,thalidomide njll)
I-GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
I-FDA-EIR-Letter-201901

UKUPHATHWA KWEKHWALITHI

Ukuphathwa kwekhwalithi1

Isiphakamiso18Amaphrojekthi Wokuhlola Ukuvumelana Kwekhwalithi asegunyaziwe4, futhi6amaphrojekthi angaphansi kokugunyazwa.

Ukuphathwa kwekhwalithi2

Uhlelo lokuphatha ikhwalithi yamazwe ngamazwe oluthuthukile lwenze isisekelo esiqinile sokuthengisa.

Ukuphathwa kwekhwalithi3

Ukugadwa kwekhwalithi kusebenza kuwo wonke umjikelezo wempilo womkhiqizo ukuze kuqinisekiswe ikhwalithi nomphumela wokwelapha.

Ukuphathwa kwekhwalithi4

Ithimba Lezindaba Zokulawula Ochwepheshe lisekela izimfuno zekhwalithi ngesikhathi sokufaka isicelo nokubhaliswa.

UKUPHATHWA KOMKHIQIZO

cpf5
cpf6

I-Korea Countec Bottled Packaging Line

cpf7
cpf8

I-Taiwan CVC Bottled Packaging Line

cpf9
cpf10

I-Italy CAM Board Packaging Line

cpf11

Umshini Wokuhlanganisa we-Fette waseJalimane

cpf12

I-Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UZAkwethu

Ukubambisana kwamazwe ngamazwe
Ukubambisana kwamazwe ngamazwe
Ukubambisana kwasekhaya
Ukubambisana kwasekhaya

  • Okwedlule:
  • Olandelayo:

  • Bhala umyalezo wakho lapha futhi usithumelele wona